Muscarinic receptor subtypes in subpopulations of human blood mononuclear cells as analyzed by RT-PCR technique

Journal of Neuroimmunology

Volumn 68, Issue 1-2, 1996, Pages 139-144

  Hellström Lindahl, Ewa ^a   Nordberg, Agneta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Leukemic cells; Lymphocytes; mRNA; Muscarinic receptors; Peripheral blood mononuclear cells; Reverse transcriptase polymerase reaction

Indexed keywords

MESSENGER RNA; MUSCARINIC RECEPTOR;

ARTICLE; B LYMPHOCYTE; CELL LINE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MONOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0030219872     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(96)00079-3     Document Type: Article

References (28)

1. Adem A., Nordberg A., Bucht G., Winblad B. Extraneuronal cholinergic markers in Alzheimer's and Parkinson's disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 10:1986;247-257.
2. Ashkenazi A., Peralta E.G., Winslow J.W., Ramachandran J., Capon D.J. Functional role of muscarinic acetylcholine receptor subtype diversity. Cold Spring Harbor Symp. Quant. Biol. 53:1988;263-272.
3. Baumgartner M.K., Wei J., Aronstam R.S. Retinoic acid-induced differentiation of human neuroblastoma cell line alters muscarinic receptor expression. Dev. Brain Res. 72:1993;305-308.
4. Bering B., Moises H.W., Müller W.E. Muscarinic cholinergic receptors on intact human lymphocytes-properties and subclass characterization. Biol. Psychiatry. 22:1987;1451-1458.
5. Bonner T.I., Buckley N.J., Young A.C., Brann M.R. Identification of a family of muscarinic acetylcholine receptor genes. Science. 237:1987;527-531.
6. Bonner T.I., Yong A.C., Brann M.R., Buckley N.J. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron. 1:1988;403-410.
7. Burnet P.W.J., Eastwood S.L., Harrison P.J. Detection and quantitation of 5-HT IA and 5.HT 2A receptor mRNAs in human hippocampus using reverse transcriptase-polymerase chain reaction (RT-PCR) technique and their correlation with binding site densities and age. Neurosci. Lett. 178:1994;85-89.
8. Chomczynski P., Sacchi N. Single step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
9. Costa L.G., Kaylor G., Murphy S.D. Muscarinic cholinergic binding sites on rat lymphocytes. Immunopharmacology. 16:1988;139-149.
10. Costa P., Traver D.J., Auger C.B., Costa L.G. Expression of cholinergic muscarinic receptor subtypes mRNA in rat blood mononuclear cells. Immunopharmacology. 28:1994;113-123.
11. Costa P., Auger C.B., Traver D.J., Costa L.G. Identification of m3, m4 and m5 subtypes of muscarinic receptor mRNA in human blood mononuclear cells. J. Neuroimmunol. 60:1995;45-51.
12. Drescher D., Upadhyay S., Wilcox E., Fex J. Analysis of muscarinic receptor subtypes in the mouse cochlea by means of the polymerase chain reaction. J. Neurochem. 59:1992;765-767.
13. Dulis B.H., Gordon M.A., Wilson I.B. Identification of muscarinic binding sites in human neutrophils by direct binding. Mol. Pharmacol. 15:1979;28-34.
14. 3H]N-methylscopolamine binding to muscarinic receptors in human peripheral blood lymphocytes: Characterization, localization on T-lymphocyte subsets and age-dependent changes. Neuropharmacology. 28:1989;719-726.
15. 3H]-N-methyl-scopolamine binding in neurological patients. Brain. 114:1991;1759-1770.
16. Genaro A.M., Cremaschi G.C., Borda E.S. Muscarinic cholinergic receptors on murine lymphocyte subpopulations. Selective interactions with second messenger response system upon pharmacological stimulation. Immunopharmacology. 26:1993;21-29.
17. 2+ in Jurkat, a human leukemic helper T lymphocyte line. Mol. Pharmacol. 43:1993;356-364.
18. Lübbert M., Koeffler H.P. Leukemic cell lines as a paradigm for myeloid differentiation. Cancer Res. 100:1988;33-62.
19. Maslinski W., Kullberg M., Nordström O., Bartfai T. Muscarinic receptors and receptor mediated actions on rat thymocytes. J. Neuroimmunol. 17:1988;265-274.
20. Maslinski W. Cholinergic receptors of lymphocytes. Brain Behav. Immun. 3:1990;1-14.
21. Nitsch R.M., Slack B.E., Wurtman R.J., Growdon J.H. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science. 258:1992;304-307.
22. Nordberg, A., Adem, A., Bucht, G., Viitanen, M. and Winblad, B. (1990) Alterations in lymphocyte receptor densities in dementia of Alzheimer type: A possible diagnostic marker. In: ed. C.J. Fowler, L.A. Carlson, C-G. Gottfries and B. Winblad, Biological Markers in Dementia of Alzheimer Type. Smith-Gordon Co. Ltd, London, pp. 149-159.
23. Nordberg A. Neuroreceptor changes in Alzheimer disease. Cerebrovasc. Brain Metab. Rev. 4:1992;303-328.
24. Rabey J.M., Shenkman L., Gilad G.M. Cholinergic muscarinic binding by human lymphocytes: Changes with aging, antagonist treatment and senile dementia of the Alzheimer type. Ann. Neurol. 20:1986;628-631.
25. Ravizza, L., Ferrero, P., Eva, C., Rocca, P., Tarenzi, L. and Benna, P. (1988) Alzheimer's disease. In: ed. E. Giacobini and R. Becker, Current Research in Alzheimer Therapy - Cholinesterase Inhibitors, Taylor and Francis, New York, pp. 355-363.
26. Steel M., Buckley N. Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure: A comparative polymerase chain reaction study. Mol. Pharmacol. 43:1993;694-701.
27. Strom T.B., Lane M.A., George K. The parallel, time-dependent, bimodal change in lymphocyte cholinergic binding activity and cholinergic influence upon lymphocyte-mediated cytotoxicity after lymphocyte activation. J. Immunol. 127:1981;705-710.
28. Wei J., Walton E.A., Milici A., Buccafusco J.J. m1-m5 Muscarinic receptor distribution in rat CNS by RT-PCR and HLPC. J. Neurochem. 63:1994;815-821.